Clinical Trials Directory

Trials / Completed

CompletedNCT05588336

Intrathecal Morphine for Thoracoscopic Surgery

Comparison of the Effects of Intrathecal Morphine at Two Different Doses in Thoracoscopic Lung Resection

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
46 (actual)
Sponsor
Cukurova University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Thoracic surgery is one of the surgeries where postoperative pain is intense. In this study, the investigators aimed to compare the efficacy of two different intrathecal morphine doses administered for postoperative analgesia according to patients' ideal body weight.

Detailed description

Patients who underwent video-assisted thoracic surgery were divided into two groups: 10 mcg/kg and 7 mcg/kg intrathecal morphine for postoperative analgesia. Intraoperative and postoperative hemodynamic variables, postoperative morphine consumption, postoperative pain scores, side effects and additional analgesic requiretment were recorded.

Conditions

Interventions

TypeNameDescription
DRUGMorphineIn the literature, intrathecal morphine doses were applied according to the patients' actual body weight and there is no study comparing intrathecal morphine dose in thoracic surgery patients.

Timeline

Start date
2022-04-25
Primary completion
2022-10-10
Completion
2022-10-10
First posted
2022-10-20
Last updated
2022-10-20

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05588336. Inclusion in this directory is not an endorsement.

Intrathecal Morphine for Thoracoscopic Surgery (NCT05588336) · Clinical Trials Directory